The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs ...
New presentations include final 64-week results from the Phase 3 QUASAR trial in patients with retinal vein occlusion, as well as full primary results from the Phase 3b ELARA trial in patients treated ...
On December 22, 2025, the U.S. Food and Drug Administration (FDA) approved an oral pill form of Wegovy — a glucagon-like peptide-1 (GLP-1) receptor agonist medication for weight loss. Until now, ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Regeneron Pharmaceuticals Inc.’s (NASDAQ: REGN) Eylea HD (aflibercept) Injection 8 mg for patients with macular edema following ...
Regeneron Pharmaceuticals (NASDAQ:REGN) announced that the U.S. FDA has extended the target action dates for two regulatory submissions related to Eylea HD (aflibercept) injection 8 mg to the fourth ...
Twinrix (hepatitis A and hepatitis B [recombinant] vaccine) can cause side effects that range from mild to serious. More common side effects include injection site soreness and headache. Talk with ...
Weight loss drugs are popular for helping patients quickly shed pounds Drugs like Ozempic are controversial for their side effects Side effects of some drugs can range from nausea to kidney failure ...
As with other drugs, icatibant can cause side effects, such as dizziness and injection reactions. If icatibant side effects become difficult to tolerate, talk with your doctor or pharmacist. Icatibant ...
ONE GRAND PRIX THIS WEEKEND. FIVE ON YOUR HEALTH TONIGHT. SEVERE SIDE EFFECTS FROM SEMAGLUTIDE, A NATIONAL STUDY FINDS THEY SENT NEARLY 25,000 PEOPLE TO THE ER FOR TREATMENT. JOINING US NOW IS DOCTOR ...
PULSAR in wAMD and PHOTON in DME/diabetic retinopathy (DR) are double-masked, active-controlled pivotal trials that were conducted in multiple centers globally. In both trials, patients were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results